tiprankstipranks
Moleculin Biotech to Announce Q3 Results in November
Company Announcements

Moleculin Biotech to Announce Q3 Results in November

Don't Miss our Black Friday Offers:

Moleculin Biotech ( (MBRX) ) just unveiled an update.

Moleculin Biotech, a pharmaceutical company focused on treating challenging tumors and viruses, is set to release its third-quarter financial results on November 8, 2024. The company will host a conference call and webcast on November 11, 2024, to discuss these results. Moleculin is advancing several promising drugs, including Annamycin for leukemia, and WP1066 targeting cancers and viruses, positioning itself for potential breakthroughs in these areas.

For detailed information about MBRX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskMoleculin Biotech Unveils New Corporate Presentation
TipRanks Auto-Generated NewsdeskMoleculin Biotech Advances Annamycin for AML Treatment
TheFlyMoleculin Biotech announces new findings on Annamycin
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App